20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T83892 | 33-BCRP Inhibitor | 33-Breast Cancer Resistance Protein Inhibitor | |
33-BCRP inhibitor is a compound that blocks the action of breast cancer resistance protein (BCRP), enhancing the susceptibility of mitoxantrone-resistant H460/MX20 lung cancer cells to the cytotoxic effects of mitoxantro... | |||
T79353 | P-gp/BCRP-IN-2 | ||
P-gp/BCRP-IN-2 (compound 15), an oxadiazole derivative, functions as a dual inhibitor targeting both the ABC transporter P-glycoprotein (IC50: 1.6 nM) and BCRP (IC50: 600 nM). Additionally, it bolsters the anti-prolifera... | |||
T63267 | P-gp/BCRP-IN-1 | ||
P-gp/BCRP-IN-1 (compound 19) is a relatively safe, orally active, and efficient inhibitor of the efflux transporters P-gp and BCRP. By inhibiting their efflux function, it reverses resistance and enhances the oral bioava... | |||
TQ0186 | Ko 143 | BCRP , ABC | |
Ko 143 is a selective inhibitor of ATP-binding cassette sub-family G member 2 (ABCG2; BCRP). | |||
T5778 | 5,7-DIMETHOXYFLAVONE | Anti-infection , P450 | |
5,7-DIMETHOXYFLAVONE possessed remarkable leishmanicidal potential. | |||
T3581 | KS176 | Potassium Channel , BCRP | |
KS176 is a potent and selective inhibitor of the breast cancer resistance protein (BCRP) multidrug transporter, showing no inhibitory activity against P-gp or MRP1. | |||
T4595 | YHO-13177 | YHO 13177,YHO13177 | BCRP |
YHO-13177 is a potent and specific inhibitor of BCRP; potentiated the cytotoxicity of SN-38 in cancer cells and no effect on P-glycoprotein–mediated paclitaxel resistance in MDR1-transduced human leukemia K562 cells. | |||
T38400 | Triclabendazole sulfoxide | TCBZ-SO | BCRP , Parasite |
Triclabendazole sulfoxide (TCBZ-SO) is a main plasma metabolite of Triclabendazole. Triclabendazole sulfoxide inhibits membrane transporter ABCG2/BCRP and exhibits anti-parasite effects. | |||
T8596 | Ceefourin 1 | MRP | |
Ceefourin 1 is a highly selective multidrug resistance protein 4 (MRP4) inhibitor. | |||
T4337 | PCI 29732 | PCI29732,PCI-29732 | Others , BCRP , BTK |
PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay. | |||
T13383 | Zamicastat | BIA 5-1058 | BCRP , Hydroxylase , P-gp |
Zamicastat (BIA 5-1058) is an inhibitor of dopamine β-hydroxylase (DBH), and is also a concentration-dependent dual inhibitor of P-gp and BCRP(IC50 values of 73.8 μM and 17.0 μM, respectively). | |||
T2657 | Elacridar | GW0918,GW120918,GF120918,GG918 | BCRP , P-gp |
Elacridar (GG918) (GF120918) is an effective BCRP and P-gp (MDR-1) inhibitor. | |||
T15355 | Fumitremorgin C | 12α-Fumitremorgin C | BCRP , Antibacterial , Antibiotic , ABC |
Fumitremorgin C (12α-Fumitremorgin C) is a mycotoxin and inhibits ABCG2/BRCP. | |||
TN3150 | 6,8-Diprenylnaringenin | Senegalensin,Lonchocarpol A | BCRP , ABC |
6,8-Diprenylnaringenin (Senegalensin) is a natural product from hop Humulus lupulus. 6,8-Diprenylnaringenin is a breast cancer resistance protein(BCRP) inhibitor with some estrogenicity. | |||
T13365 | YHO-13351 free base | BCRP | |
YHO-13351 free base is the water-soluble prodrug of YHO-13177 which is an inhibitor of BCRP . | |||
T19649 | PF-06273340 | PF 6273340,PF 06273340,PF6273340,PF-6273340 | Trk receptor |
PF-06273340 is an effective, Selective, and Peripherally Restricted Pan-Trk inhibitor (IC50: Trk-A = 6 nM; Trk-B = 4 nM; Trk-C = 3 nM). PF-06273340 has low metabolic turnover in HLM and hHep is a good substrate for efflu... | |||
T67821 | GS-9191 PM | BCRP , Antiviral | |
GS-9191 PM is a novel antitumorviral compound, a bis-amide prodrug of the nucleotide analog 9-(2-phosphonomethoxyethyl)-N6-cyclopropyl-2,6-diaminopurine (cPrPMEDAP).GS-9191 PM is a potent inhibitor of MDR1 and BCRP.GS-91... | |||
T16113 | ML753286 | AMPK | |
ML753286 has high permeability and low to medium clearance in rodent and human liver S9 fractions. ML753286 is an orally active and selective inhibitor of BCRP (IC50: 0.6 μM). It is also stable in plasma across species. | |||
T10490 | (S)-ML753286 | Others | |
(S)-ML753286 is a breast cancer resistance protein (BCRP) inhibitor (IC50: 0.6 μM on BCRP efflux transporter). | |||
T22680 | CP-100356 hydrochloride | CP-100356 HCl,CP 100356 hydrochloride | BCRP |
CP-100356 hydrochloride is an orally active and low micromolar dual inhibitor of MDR1 (P-gp) and BCRP, a nucleotide-derived substrate analogue with inhibitory effects on MDR1-mediated Calcein-AM transporter and BCRP-medi... |